Cortical collecting duct principal cell: ENaC and potassium secretion

Collecting duct · 2-3% Na+ ENaC/ROMK Aldosterone Amiloride

Aldosterone-regulated fine control of sodium and potassium: sodium entering through the epithelial Na+ channel makes the lumen electronegative, which drives potassium secretion through ROMK. This is the mechanism behind every hyperaldosteronism picture and every potassium-sparing diuretic.

Traced from the start

  1. Glomerular filtration barrier
  2. Proximal tubule: Na+/H+ exchange and bicarbonate reclamation
  3. Thick ascending limb of Henle (NKCC2)
  4. Early distal convoluted tubule: thiazide-sensitive NaCl cotransporter
  5. Cortical collecting duct principal cell: ENaC and potassium secretion

Detail

Reabsorbs
~2-3% of filtered Na+ via ENaC; a small amount, but it is where final Na+ excretion (0.1-1% of the filtered load) is set
Secretes
K+ through ROMK (and flow-activated BK channels) down the electrical gradient created by ENaC (lumen ~-40 mV); K+ secretion rises with distal Na+ delivery, tubular flow, aldosterone and alkalosis
Transporter
Apical ENaC and ROMK; basolateral Na+/K+-ATPase
Hormone
Aldosterone via the mineralocorticoid receptor (11-beta-HSD2 shields it from cortisol) induces SGK1, more ENaC, ROMK and Na+/K+-ATPase; ANP inhibits Na+ reabsorption via cGMP; ADH modestly increases ENaC
Diuretic
Potassium-sparing: amiloride and triamterene block ENaC from the lumen; spironolactone and eplerenone antagonise the mineralocorticoid receptor; natriuresis is weak (up to ~3% of filtered Na+) but they blunt K+ and H+ loss from upstream diuretics

When it goes wrong

Primary hyperaldosteronism (Conn adenoma or bilateral adrenal hyperplasia)

Resistant hypertension with hypokalaemia and metabolic alkalosis and suppressed renin; screen with the aldosterone:renin ratio

Spironolactone or amiloride combined with an ACE inhibitor, ARB, NSAID, trimethoprim or CKD

Hyperkalaemia; spironolactone also causes gynaecomastia (eplerenone does not)

Liddle syndrome (gain-of-function ENaC)

Early-onset hypertension with hypokalaemic alkalosis and low renin AND low aldosterone; responds to amiloride, not spironolactone; liquorice or 11-beta-HSD2 deficiency gives the same picture by letting cortisol act on the receptor

Low distal Na+ delivery (volume depletion) or hypoaldosteronism (Addison disease, ACE inhibitor, heparin, type 4 RTA)

Impaired K+ secretion and hyperkalaemia; loop and thiazide diuretics do the opposite by raising delivery and flow

Practise this structure

1 question in the bank tagged Aldosterone.